(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions ISO RGD:619837 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NEO1 mRNA CTD PMID:25729387 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE increases expression ISO RGD:619837 6480464 Topotecan results in increased expression of NEO1 mRNA CTD PMID:25729387 17beta-estradiol multiple interactions ISO RGD:733424 6480464 [Estradiol co-treated with Progesterone] results in increased expression of NEO1 mRNA CTD PMID:20660070 17beta-estradiol multiple interactions ISO RGD:619837 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of NEO1 mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NEO1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NEO1 gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NEO1 mRNA CTD PMID:28213091 2,4-dinitrotoluene affects expression ISO RGD:619837 6480464 2,4-dinitrotoluene affects the expression of NEO1 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of NEO1 mRNA CTD PMID:26251327 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4,4'-diaminodiphenylmethane results in increased expression of NEO1 mRNA CTD PMID:18648102 4-hydroxynon-2-enal decreases expression ISO RGD:733424 6480464 4-hydroxy-2-nonenal results in decreased expression of NEO1 mRNA CTD PMID:12419474 6-propyl-2-thiouracil increases expression ISO RGD:619837 6480464 Propylthiouracil results in increased expression of NEO1 mRNA CTD PMID:24780913 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of NEO1 mRNA CTD PMID:19770486 ammonium chloride affects expression ISO RGD:619837 6480464 Ammonium Chloride affects the expression of NEO1 mRNA CTD PMID:16483693 apigenin increases expression EXP 6480464 Apigenin results in increased expression of NEO1 mRNA CTD PMID:22359648 atrazine increases expression ISO RGD:733424 6480464 Atrazine results in increased expression of NEO1 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of NEO1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:733424 6480464 Benzo(a)pyrene results in decreased expression of NEO1 mRNA CTD PMID:21632981 bisphenol A multiple interactions ISO RGD:619837 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of NEO1 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:733424 6480464 bisphenol A results in increased expression of NEO1 mRNA CTD PMID:29275510 bisphenol A decreases expression ISO RGD:619837 6480464 bisphenol A results in decreased expression of NEO1 mRNA CTD PMID:25181051 cobalt dichloride increases expression ISO RGD:619837 6480464 cobaltous chloride results in increased expression of NEO1 mRNA CTD PMID:24386269 cocaine multiple interactions EXP 6480464 [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein] which affects the expression of NEO1 protein; more ... CTD PMID:15056714 cyclosporin A decreases expression ISO RGD:733424 6480464 Cyclosporine results in decreased expression of NEO1 mRNA CTD PMID:25562108 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of NEO1 mRNA CTD PMID:21266533 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of NEO1 mRNA CTD PMID:22246474 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NEO1 mRNA CTD PMID:30529165 disodium selenite decreases expression EXP 6480464 Sodium Selenite results in decreased expression of NEO1 mRNA CTD PMID:23274088 diuron decreases expression ISO RGD:619837 6480464 Diuron results in decreased expression of NEO1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733424 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEO1 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:733424 6480464 Ethanol results in increased expression of NEO1 mRNA CTD PMID:28986285 ethanol increases expression EXP 6480464 Ethanol results in increased expression of NEO1 mRNA CTD PMID:30319688 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of NEO1 mRNA CTD PMID:30319688 formaldehyde increases expression ISO RGD:619837 6480464 Formaldehyde results in increased expression of NEO1 mRNA CTD PMID:12679049 hydrogen peroxide affects expression ISO RGD:733424 6480464 Hydrogen Peroxide affects the expression of NEO1 mRNA CTD PMID:20044591 lead(0) affects splicing ISO RGD:733424 6480464 Lead affects the splicing of NEO1 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:733424 6480464 Lead affects the splicing of NEO1 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:733424 6480464 [Lipopolysaccharides co-treated with resveratrol] results in increased expression of NEO1 mRNA CTD PMID:26667767 menadione affects expression ISO RGD:733424 6480464 Vitamin K 3 affects the expression of NEO1 mRNA CTD PMID:20044591 methyl methanesulfonate increases expression ISO RGD:733424 6480464 Methyl Methanesulfonate results in increased expression of NEO1 mRNA CTD PMID:23649840 N-nitrosodiethylamine multiple interactions ISO RGD:619837 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of NEO1 mRNA CTD PMID:20360939 nickel atom decreases expression ISO RGD:733424 6480464 Nickel results in decreased expression of NEO1 mRNA CTD PMID:25583101 oxaliplatin multiple interactions ISO RGD:619837 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NEO1 mRNA CTD PMID:25729387 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of NEO1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:733424 6480464 Acetaminophen results in increased expression of NEO1 mRNA CTD PMID:22230336 phenethyl caffeate multiple interactions ISO RGD:619837 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of NEO1 mRNA CTD PMID:20360939 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of NEO1 mRNA CTD PMID:23091169 progesterone multiple interactions ISO RGD:733424 6480464 [Estradiol co-treated with Progesterone] results in increased expression of NEO1 mRNA CTD PMID:20660070 Ptaquiloside decreases expression EXP 6480464 ptaquiloside results in decreased expression of NEO1 mRNA CTD PMID:23274088 resveratrol multiple interactions ISO RGD:733424 6480464 [Lipopolysaccharides co-treated with resveratrol] results in increased expression of NEO1 mRNA CTD PMID:26667767 SB 431542 multiple interactions ISO RGD:733424 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEO1 mRNA CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of NEO1 mRNA CTD PMID:23221170 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of NEO1 mRNA CTD PMID:21795629 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of NEO1 mRNA CTD PMID:21795629 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of NEO1 mRNA CTD PMID:17484886 topotecan increases expression ISO RGD:619837 6480464 Topotecan results in increased expression of NEO1 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:619837 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NEO1 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:733424 6480464 trichostatin A results in decreased expression of NEO1 mRNA CTD PMID:24935251 urethane increases expression ISO RGD:733424 6480464 Urethane results in increased expression of NEO1 mRNA CTD PMID:28818685 valproic acid increases methylation ISO RGD:733424 6480464 Valproic Acid results in increased methylation of NEO1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:733424 6480464 Valproic Acid affects the expression of NEO1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:733424 6480464 Valproic Acid results in decreased expression of NEO1 mRNA CTD PMID:26272509 valproic acid multiple interactions ISO RGD:733424 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEO1 mRNA CTD PMID:27188386
Biological Process axon guidance IEA InterPro:IPR033024 2290270 UniProtKB GO_REF:0000002 MGI:MGI:2152098 cell adhesion IEA UniProtKB-KW:KW-0130 2290270 UniProtKB GO_REF:0000004 MGI:MGI:1354194 iron ion homeostasis IMP MGI:MGI:3665445 2290270 MGI MGI:MGI:4455113 PMID:20065295 iron ion homeostasis ISO UniProtKB:Q92859 2290270 MGI GO_REF:0000008 MGI:MGI:2154458 myoblast fusion IMP 2290270 MGI MGI:MGI:3521604 PMID:15520228 negative regulation of axon regeneration IMP 2290270 MGI MGI:MGI:5702499 PMID:26651291 negative regulation of neuron death ISO RGD:619837 2290270 RGD GO_REF:0000096 MGI:MGI:4417868 negative regulation of protein secretion IDA 2290270 MGI MGI:MGI:4455113 PMID:20065295 nervous system development IEA InterPro:IPR033024 2290270 UniProtKB GO_REF:0000002 MGI:MGI:2152098 neuron migration IMP 2290270 MGI MGI:MGI:5702499 PMID:26651291 positive regulation of BMP signaling pathway IGI MGI:MGI:88177 2290270 MGI MGI:MGI:4455113 PMID:20065295 regulation of axon regeneration IGI MGI:MGI:2443718 2290270 MGI MGI:MGI:5702499 PMID:26651291 regulation of neuron migration IGI MGI:MGI:1096335|MGI:MGI:2443718 2290270 MGI MGI:MGI:5702499 PMID:26651291 regulation of transcription, DNA-templated IDA 2290270 MGI MGI:MGI:3521604 PMID:15520228 Cellular Component cell surface IDA 2290270 MGI MGI:MGI:5702499 PMID:26651291 Golgi apparatus ISO UniProtKB:Q92859 2290270 MGI GO_REF:0000096 MGI:MGI:4834177 integral component of membrane IEA InterPro:IPR010560 2290270 UniProtKB GO_REF:0000002 MGI:MGI:2152098 integral component of membrane IEA UniProtKB-KW:KW-0812 2290270 UniProtKB GO_REF:0000004 MGI:MGI:1354194 integral component of plasma membrane IEA InterPro:IPR033024 2290270 UniProtKB GO_REF:0000002 MGI:MGI:2152098 intracellular vesicle IDA 2290270 MGI MGI:MGI:5702499 PMID:26651291 membrane IDA 2290270 MGI MGI:MGI:5702499 PMID:26651291 neuronal cell body ISO RGD:619837 2290270 RGD GO_REF:0000096 MGI:MGI:4417868 nucleoplasm ISO UniProtKB:Q92859 2290270 MGI GO_REF:0000096 MGI:MGI:4834177 plasma membrane ISO UniProtKB:Q92859 2290270 MGI GO_REF:0000096 MGI:MGI:4834177 plasma membrane protein complex ISO UniProtKB:Q92859 2290270 MGI GO_REF:0000096 MGI:MGI:4834177 Molecular Function BMP receptor binding IPI UniProtKB:Q6ZVN8 2290270 BHF-UCL MGI:MGI:5644024 PMID:18326817 cadherin binding IDA 2290270 MGI MGI:MGI:3521604 PMID:15520228 co-receptor binding ISO UniProtKB:Q92859 2290270 MGI GO_REF:0000096 MGI:MGI:4834177 protein binding IPI UniProtKB:O88971 2290270 MGI MGI:MGI:3521604 PMID:15520228 protein binding IPI UniProtKB:F8VQB6 2290270 IntAct MGI:MGI:4839446 PMID:17237772 protein binding IPI UniProtKB:Q9HD67 2290270 MGI MGI:MGI:5702499 PMID:26651291 protein binding IPI UniProtKB:Q6NW40 2290270 IntAct MGI:MGI:5915531 PMID:25938661 signaling receptor activity IPI UniProtKB:Q9R1A3 2290270 MGI MGI:MGI:3521604 PMID:15520228 signaling receptor activity IPI UniProtKB:Q6PCX7 2290270 MGI MGI:MGI:5702499 PMID:26651291 signaling receptor activity IPI UniProtKB:Q52KR2 2290270 MGI MGI:MGI:5702499 PMID:26651291
Gene-Chemical Interaction Annotations
